Published in Pharmacology on July 08, 2009
Neuropsychiatric side effects of cyclobenzaprine. BMJ Case Rep (2013) 0.75
An examination of TOR1A variants in recurrent major depression. Int J Mol Epidemiol Genet (2012) 0.75
In vitro evaluation of the sinus sagittalis superior thrombosis model in the rat using 3D micro- and nanocomputed tomography. Neuroradiology (2009) 1.72
Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: a randomized controlled trial. Eur Heart J (2009) 1.64
Aggravation of infarct formation by brain swelling in a large territorial stroke: a target for neuroprotection? J Neurosurg (2008) 1.53
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke (2011) 1.39
Training of executive functions in Parkinson's disease. J Neurol Sci (2006) 1.24
Identification of embolic stroke patterns by diffusion-weighted MRI in clinically defined lacunar stroke syndromes. Stroke (2005) 1.21
Cerebral vein thrombosis: clinical manifestation and diagnosis. BMC Neurol (2011) 1.16
Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood (2007) 1.07
Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke (2009) 1.03
Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke (2013) 1.01
Nestin expression is lost in a neural stem cell line through a mechanism involving the proteasome and Notch signalling. Brain Res Dev Brain Res (2004) 0.98
The frequency and significance of 'striatal toe' in parkinsonism. Parkinsonism Relat Disord (2002) 0.97
Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST). J Rehabil Med (2014) 0.93
Making stem cell lines suitable for transplantation. Cell Transplant (2007) 0.92
Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity. J Rehabil Med (2011) 0.90
A new model of reversible sinus sagittalis superior thrombosis in the rat: magnetic resonance imaging changes. Neurosurgery (2005) 0.89
Midline-shift corresponds to the amount of brain edema early after hemispheric stroke--an MRI study in rats. J Neurosurg Anesthesiol (2007) 0.88
Intravenous immunoglobulin reduces infarct volume but not edema formation in acute stroke. Neuroimmunomodulation (2009) 0.87
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry. J Neural Transm (Vienna) (2014) 0.87
Patent foramen ovale and cryptogenic stroke: the hole story. Stroke (2013) 0.86
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology. Neurol Sci (2013) 0.85
Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res Brain Res Protoc (2004) 0.85
Evaluation of the middle cerebral artery occlusion techniques in the rat by in-vitro 3-dimensional micro- and nano computed tomography. BMC Neurol (2010) 0.84
Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurol (2010) 0.83
Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale. BMC Neurol (2010) 0.82
Motor skill learning, retention, and control deficits in Parkinson's disease. PLoS One (2011) 0.81
Jugular valve incompetence in transient global amnesia. A problem revisited. J Neuroimaging (2013) 0.81
Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults. J Neurol (2012) 0.80
Clinical application of transcranial colour-coded duplex sonography--a review. Eur J Neurol (2002) 0.80
Reversible MR imaging abnormalities following cerebral venous thrombosis. AJNR Am J Neuroradiol (2005) 0.80
Sinus thrombosis after a jump from a small rock and a sneezing attack: minor endothelial trauma as a precipitating factor for cerebral venous thrombosis? Headache (2004) 0.79
Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis. Neuroimmunomodulation (2009) 0.79
Cerebral venous thrombosis with nonhemorrhagic lesions: clinical correlates and prognosis. Cerebrovasc Dis (2010) 0.79
Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis. J Neurol (2004) 0.78
Intracranial venous hemodynamics in patients with midline dislocation due to postischemic brain edema. Stroke (2002) 0.77
Aging, physical activity, and disease prevention. J Aging Res (2011) 0.77
A rat model for cerebral air microembolisation. J Neurosci Methods (2010) 0.77
Comments on 'computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction'. Cerebrovasc Dis (2004) 0.77
EmboDop: insufficient automatic microemboli identification. Stroke (2006) 0.76
Increased monocyte tissue factor activity in women following cerebral venous thrombosis. J Neurol (2003) 0.76
Conservative medical treatment and intravenous thrombolysis in acute stroke from carotid T occlusion. Cerebrovasc Dis (2005) 0.76
Prognostic value of transcranial sonography in acute stroke patients. Eur Neurol (2008) 0.76
Neurovascular coupling in Parkinson's disease patients: effects of dementia and acetylcholinesterase inhibitor treatment. J Alzheimers Dis (2010) 0.76
Erratum: Chronic cerebrospinal venous insufficiency: the end of "The Big Idea"? Brain Behav (2016) 0.75
Strategies for the reduction of cerebral microembolism during transmyocardial laser revascularization. Lasers Surg Med (2004) 0.75
A sudden arterial blood pressure decrease is compensated by an increase in intracranial blood volume. J Neurol (2002) 0.75
Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience. Am J Phys Med Rehabil (2017) 0.75
No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability. J Neurol (2013) 0.75